跳轉至內容
Merck
  • Consequences of misdiagnosis and mismanagement of Takotsubo cardiomyopathy.

Consequences of misdiagnosis and mismanagement of Takotsubo cardiomyopathy.

Acute cardiac care (2012-12-12)
Chirayu Vyas, Sanjay Shah, Sameer Pancholy, Tejas Patel, Isam Moussa
摘要

We report a patient who presented with takotsubo cardiomyopathy but was misdiagnosed as an anterior wall ST elevation myocardial infarction (AWMI). We illustrate how misdiagnosis led to mismanagement by initiating intravenous inotropic agents that led to further hemodynamic compromise. Subsequent withdrawal of the inotropic agents and simultaneous administration of oral metoprolol therapy led to hemodynamic and clinical improvement re-affirming the diagnosis of takotsubo cardiomyopathy.

材料
產品編號
品牌
產品描述

Supelco
美托洛尔 酒石酸酯 溶液, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Supelco
美托洛尔 (+)-酒石酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
美托洛尔 (+)-酒石酸盐, European Pharmacopoeia (EP) Reference Standard